1. Home
  2. KVYO vs TERN Comparison

KVYO vs TERN Comparison

Compare KVYO & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$14.24

Market Cap

4.3B

Sector

N/A

ML Signal

HOLD

Logo Terns Pharmaceuticals Inc.

TERN

Terns Pharmaceuticals Inc.

HOLD

Current Price

$52.97

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
TERN
Founded
2012
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.8B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
KVYO
TERN
Price
$14.24
$52.97
Analyst Decision
Strong Buy
Buy
Analyst Count
21
12
Target Price
$34.48
$45.22
AVG Volume (30 Days)
5.5M
6.2M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
8.04
EPS
0.03
N/A
Revenue
$1,234,019,000.00
N/A
Revenue This Year
$24.47
N/A
Revenue Next Year
$19.66
N/A
P/E Ratio
$476.67
N/A
Revenue Growth
31.63
N/A
52 Week Low
$13.53
$3.55
52 Week High
$36.76
$53.19

Technical Indicators

Market Signals
Indicator
KVYO
TERN
Relative Strength Index (RSI) 40.10 74.51
Support Level $13.84 $52.42
Resistance Level $21.74 $53.19
Average True Range (ATR) 0.99 0.07
MACD -0.02 -0.31
Stochastic Oscillator 9.48 97.30

Price Performance

Historical Comparison
KVYO
TERN

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About TERN Terns Pharmaceuticals Inc.

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Share on Social Networks: